Jeffrey S Miller Selected Research

NK Cell Lectin-Like Receptor Subfamily C

12/2021	Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.
1/2019	Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.
1/2018	Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey S Miller Research Topics

Disease

77	Neoplasms (Cancer) 12/2022 - 01/2002
24	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 04/2005
22	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 07/2002
20	Leukemia 12/2021 - 11/2009
15	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2004
14	Infections 12/2021 - 01/2002
6	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 10/2013
6	Lymphoma (Lymphomas) 01/2022 - 02/2005
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020 - 08/2009
5	Virus Diseases (Viral Diseases) 01/2022 - 07/2006
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 10/2007
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 02/2005
4	Breast Neoplasms (Breast Cancer) 08/2021 - 02/2003
4	Melanoma (Melanoma, Malignant) 11/2018 - 04/2008
4	Carcinoma (Carcinomatosis) 01/2018 - 05/2013
3	Multiple Myeloma 01/2022 - 06/2004
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 10/2006
3	Fever (Fevers) 02/2016 - 09/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 11/2018
2	Viremia 01/2021 - 12/2017
2	Thrombocytopenia (Thrombopenia) 05/2020 - 02/2016
2	Neuroblastoma 12/2019 - 01/2017
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2019 - 01/2017
2	Cytokine Release Syndrome 01/2019 - 03/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 03/2004
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 12/2012
2	Fatigue 11/2018 - 02/2016
2	Nausea 11/2018 - 02/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2018 - 03/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 12/2008
2	Communicable Diseases (Infectious Diseases) 01/2018 - 03/2012
2	Stroke (Strokes) 01/2018 - 07/2016
2	Infertility (Sterility) 02/2013 - 03/2007
1	Vaccinia 01/2022
1	HIV Infections (HIV Infection) 01/2022

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 01/2022 - 01/2002
16	Interleukin-15 (Interleukin 15)IBA 01/2022 - 09/2011
10	LigandsIBA 12/2019 - 11/2002
9	Interleukin-2 (IL2)IBA 01/2022 - 07/2003
7	VaccinesIBA 11/2022 - 11/2005
7	AntigensIBA 01/2022 - 09/2003
6	AntibodiesIBA 12/2022 - 05/2010
6	ALT-803IBA 11/2018 - 12/2017
5	KIR ReceptorsIBA 01/2020 - 08/2006
4	Chimeric Antigen ReceptorsIBA 12/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2014
4	Monoclonal AntibodiesIBA 10/2020 - 01/2013
4	Single-Chain AntibodiesIBA 01/2020 - 02/2003
4	Rituximab (Mabthera)FDA Link 12/2019 - 11/2010
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 07/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 04/2005
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 01/2013
3	NK Cell Lectin-Like Receptor Subfamily CIBA 12/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 12/2021 - 12/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 07/2009
3	InterleukinsIBA 01/2019 - 10/2013
3	fludarabineIBA 01/2019 - 04/2005
3	HLA-C Antigens (HLA-C)IBA 01/2018 - 05/2014
3	Pharmaceutical PreparationsIBA 10/2017 - 05/2013
2	micaIBA 11/2022 - 11/2009
2	Immunoglobulin G (IgG)IBA 01/2022 - 11/2018
2	Bispecific AntibodiesIBA 01/2022 - 05/2013
2	Trastuzumab (Herceptin)FDA Link 08/2021 - 07/2003
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 09/2017
2	pembrolizumabIBA 01/2021 - 01/2018
2	HLA-Bw4 antigenIBA 12/2019 - 01/2017
2	Interleukin-12 (IL 12)IBA 01/2019 - 03/2012
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 09/2003
2	TroponinIBA 01/2018 - 12/2010
2	EpitopesIBA 01/2018 - 02/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2002
2	Antiviral Agents (Antivirals)IBA 12/2017 - 07/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 11/2009
2	Epithelial Cell Adhesion MoleculeIBA 11/2016 - 05/2013
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2016 - 03/2016
2	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 05/2013
2	Silicon Dioxide (Silica)FDA LinkGeneric 06/2014 - 04/2008
2	ChemokinesIBA 03/2014 - 12/2012
2	EndotoxinsIBA 02/2013 - 03/2007
2	Toll-Like Receptor 7IBA 10/2012 - 12/2007
2	Natural Killer Cell ReceptorsIBA 01/2012 - 10/2010
2	HLA-B Antigens (HLA-B)IBA 07/2009 - 08/2006
1	Zinc Finger E-box-Binding Homeobox 1IBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	chondroitin sulfate proteoglycan 4IBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	cytomegalovirus-specific hyperimmune globulinIBA 01/2022

Therapy/Procedure

45	Therapeutics 12/2022 - 01/2002
29	Immunotherapy 12/2022 - 01/2002
27	Cell Transplantation 01/2022 - 03/2004
26	Transplantation 01/2022 - 11/2002
12	Drug Therapy (Chemotherapy) 02/2022 - 06/2004
11	Hematopoietic Stem Cell Transplantation 01/2022 - 02/2005
3	Stem Cell Transplantation 01/2022 - 10/2006
3	Autologous Transplantation 01/2022 - 06/2004
2	Homologous Transplantation 01/2020 - 05/2008
2	Immunomodulation 09/2017 - 11/2011
2	Donor Selection 05/2014 - 10/2010
1	Adjuvant Chemotherapy 02/2022
1	Art Therapy 01/2022